Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Endocrinological Investigation

• Publication date

  2005-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF03347225PMID 16075928
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin‐like growth factor‐1 deficiency determines increased intima–media thickness at common carotid arteries in adult patients with growth hormone deficiency

  2004cited by this paper
• The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study.

  2004cited by this paper
• Associations of insulin‐like growth factors, insulin‐like growth factor binding proteins and acid‐labile subunit with coronary heart disease

  2004cited by this paper
• A study of carotid intima-media thickness in GH-deficient Japanese adults during onset among adults and children.

  2003cited by this paper
• Serum Insulin-like Growth Factor I and Risk for Heart Failure in Elderly Individuals without a Previous Myocardial Infarction: The Framingham Heart Study

  2003cited by this paper
• Cardiovascular consequences of early-onset growth hormone excess.

  2002cited by this paper
• Effect of a six-month treatment with lanreotide on cardiovascular risk factors and arterial intima-media thickness in patients with acromegaly.

  2002cited by this paper
• Heart Disease : A Population-Based Case-Control Study Low Serum Insulin-Like Growth Factor I Is Associated With Increased Risk of Ischemic

  2002cited by this paper
• Intima‐media thickness in cardiovascularly asymptomatic hypopituitary adults with growth hormone deficiency: relation to body mass index, gender, and other cardiovascular risk factors

  2002cited by this paper
• Low Serum Insulin-Like Growth Factor I Is Associated With Increased Risk of Ischemic Heart Disease: A Population-Based Case-Control Study

  2002cited by this paper
• Early vascular alterations in acromegaly.

  2002cited by this paper
• Cardiovascular disease and insulin-like growth factor I.

  2002cited by this paper
• Increased arterial intima‐media thickness by B‐M mode echodoppler ultrasonography in acromegaly

  2001cited by this paper
• Characterization of premature atherosclerosis of carotid arteries in acromegalic patients

  2001cited by this paper
• Association between premature mortality and hypopituitarism

  2001cited by this paper
• Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group.

  2001cited by this paper
• Vascular reactivity in acromegalic patients: preliminary evidence for regional endothelial dysfunction and increased sympathetic vasoconstriction

  2000cited by this paper
• The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency.

  2000cited by this paper
• The insulin-like growth factor axis: A review of atherosclerosis and restenosis.

  2000cited by this paper
• Serum insulin-like growth factor-I level is independently associated with coronary artery disease progression in young male survivors of myocardial infarction: beneficial effects of bezafibrate treatment.

  2000cited by this paper
• Decrease in carotid intima-media thickness after one year growth hormone (GH) treatment in adults with GH deficiency.

  1999cited by this paper
• Serum total IGF-I, free IGF-I, and IGFB-1 levels in an elderly population: relation to cardiovascular risk factors and disease.

  1998cited by this paper
• Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults.

  1998cited by this paper
• Mechanisms and pathophysiologic significance of insulinʼs vascular action

  1998cited by this paper
• The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity.

  1998cited by this paper
• Diurnal variation in serum insulin‐like growth factor (IGF)‐I and IGF binding protein‐3 concentrations during daily subcutaneous injections of recombinant human growth hormone in GH‐deficient adults

  1997cited by this paper
• Increased arterial intima-media thickness in childhood-onset growth hormone deficiency.

  1997cited by this paper
• Increased cerebrovascular mortality in patients with hypopituitarism

  1997cited by this paper
• Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study.

  1996cited by this paper
• Hypertension control. Report of a WHO Expert Committee.

  1996cited by this paper
• Insulin-like growth factor-I and angiographically documented coronary artery disease.

  1996cited by this paper
• Lipids, risk factors and ischaemic heart disease.

  1996cited by this paper
• Insulin-like growth factor-1 and angiographically documented coronary artery disease

  1996cited by this paper
• The effect of hypopituitarism on life expectancy.

  1996cited by this paper
• Insulin-like growth factor I and its binding proteins in the cardiovascular system.

  1995cited by this paper
• Noninvasive Ultrasonic Biopsy: Evaluation of Early Arteriosclerotic Lesions Progression in Normal Asymptomatic, Hyperlipidemic, and Diabetic Subjects

  1993cited by this paper
• Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults.

  1992cited by this paper
• The insulin-like growth factors: their putative role in atherogenesis.

  1991cited by this paper
• Premature mortality due to cardiovascular disease in hypopituitarism.

  1990cited by this paper
• Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man.

  1990cited by this paper
• Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel.

  1988cited by this paper
• Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

  1985cited by this paper
• Consensus conference: Treatment of hypertriglyceridemia.

  1984cited by this paper
• Treatment of hypertriglyceridemia. I. Total caloric restriction followed by refeeding a low carbohydrate, high fat diet in the carbohydrate-induced type (eight cases). II. Low fat diet plus medium-chain triglycerides in the fat-induced type (two cases).

  1966cited by this paper
• Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Growth Hormone (GH) Treatment Reverses Early Atherosclerotic Changes in GH-Deficient Adults*

  year unknowncited by this paper

• IGF Signaling in the Heart in Health and Disease

  2024cites this paper
• New insights on the cardiovascular effects of IGF-1

  2023cites this paper
• INFLUENCE OF INSULIN-LIKE GROWTH FACTOR-I LEVELS ON THE COURSE OF ACUTE MYOCARDIAL INFARCTION: review

  2022cites this paper
• Application of a Machine Learning Technology in the Definition of Metabolically Healthy and Unhealthy Status: A Retrospective Study of 2567 Subjects Suffering from Obesity with or without Metabolic Syndrome

  2022cites this paper
• Clinical and functional outcome of total hip arthroplasty in patients with acromegaly: mean twelve year follow-up

  2022cites this paper
• Relation of IGF-I with subclinical cardiovascular markers including intima-media thickness, left ventricular mass index and NT-proBNP.

  2019cites this paper
• Arthropathy in acromegaly: a questionnaire-based estimation of motor disability and its relation with quality of life and work productivity

  2019cites this paper
• Research on Correlation Between Serum IGF-1, TNF-a and Atherosclerosis in Patients with Diabetes

  2019cites this paper
• Effects of IGF-1 on the cardiovascular system.

  2019cites this paper
• Role of IGF-binding proteins in regulating IGF responses to changes in metabolism.

  2018cites this paper
• Evaluation of Cardiovascular Risk With Arterial Stiffness in Patients with Nonfunctioning Pituitary Adenoma.

  2018cites this paper
• Growth and Growth Factors

  2018cites this paper
• Decreased plasma concentrations of BDNF and IGF-1 in abstinent patients with alcohol use disorders

  2017cites this paper
• Atheroprotective Properties of Serum IGF-1 in the Carotid and Coronary Territories and Beneficial Role on the Physical Fitness of the Oldest Old.

  2016cites this paper
• Evaluation of Serum GH, IGF-1, and IGFBP-3 Levels as Biomarkers in The Diagnosis of Acute Myocardial Infarction

  2016cites this paper
• Insulin, Glucagon and Growth Hormone and CIMT in Glucose Intolerance

  2016cites this paper
• Cardiovascular risk in adult hypopituitaric patients with growth hormone deficiency: is there a role for vitamin D?

  2016cites this paper
• Metabolic, anabolic, and mitogenic insulin responses: A tissue-specific perspective for insulin receptor activators.

  2015cites this paper
• Clinical and Economic Burden of Commercially Insured Patients with Acromegaly in the United States: A Retrospective Analysis

  2015cites this paper
• The role of insulin-like growth factor-1 in development of coronary no-reflow and severity of coronary artery disease in patients with acute myocardial infarction

  2014cites this paper
• Low circulating level of IGF-1 is a distinct indicator for the development of cardiovascular disease caused by combined hyperglycemia and dyslipidemia.

  2014cites this paper
• Could different treatment approaches in acromegaly influence life expectancy? A comparative study between Bulgaria and Campania (Italy).

  2014cites this paper
• A polymorphism at IGF1 locus is associated with carotid intima media thickness and endothelium-dependent vasodilatation.

  2014cites this paper
• Oxidized LDL lipids as a risk factor for atherosclerosis

  2014cites this paper
• Insulin Like Growth Factor Binding Protein-5 Regulates Excessive Vascular Smooth Muscle Cell Proliferation in Spontaneously Hypertensive Rats via ERK 1/2 Phosphorylation

  2013cites this paper
• Low incidence of pathology detection and high cost of screening in the evaluation of asymptomatic short children.

  2013cites this paper
• Insulin-like growth factor-1 and lipoprotein profile in cord blood of preterm small for gestational age infants

  2013cites this paper
• Growth hormone and cancer: an update on progress

  2013cites this paper
• One‐hour post‐load plasma glucose and IGF‐1 in hypertensive patients

  2012cites this paper
• Growth Hormone and the Cardiovascular System

  2012cites this paper
• Association between insulin like growth factor-1 and lipoprotein metabolism in stable angina patients on statin therapy: a pilot study.

  2012cites this paper
• Sleep apnea in acromegaly: a review on prevalence, pathogenetic aspects and treatment

  2012cites this paper
• Preoperative Lanreotide Treatment Improves Outcome in Patients with Acromegaly Resulting from Invasive Pituitary Macroadenoma

  2012cites this paper
• IGF-1 and atherothrombosis: relevance to pathophysiology and therapy.

  2011cites this paper
• Musculoskeletal complications of acromegaly: what radiologists should know about early manifestations

  2011cites this paper
• OPPORTUNITY : a large-scale randomized clinical trial of growth hormone in hemodialysis patients

  2011cites this paper
• Determinants of cardiac disease in newly diagnosed patients with acromegaly: results of a 10 year survey study.

  2011cites this paper
• Mechano-Growth Factor in the Failing Heart

  2011cites this paper
• Prevalence of the metabolic syndrome in moderately-severely obese subjects with and without growth hormone deficiency

  2010cites this paper
• NADPH Oxidases Regulate CD44 and Hyaluronic Acid Expression in Thrombin-treated Vascular Smooth Muscle Cells and in Atherosclerosis*

  2010cites this paper
• Effects of ACE-inhibition on IGF-1 and IGFBP-3 concentrations in older adults with high cardiovascular risk profile

  2010cites this paper
• Circulating Insulin-Like Growth Factor-1 and Its Binding Protein-3: Metabolic and Genetic Correlates in the Community

  2010cites this paper
• Prevalence of the metabolic syndrome in moderately-severely obese subjects with and without growth hormone deficiency.

  2010cites this paper
• Peripheral blood concentrations of TGFβ1, IGF-1 and bFGF and remodelling of the left ventricle and blood vessels in hypertensive patients.

  2010cites this paper
• Positive association between plasma IGF1 and high-density lipoprotein cholesterol levels in adult nondiabetic subjects.

  2010cites this paper
• Growth hormone treatment on atherosclerosis: results of a 5-year open, prospective, controlled study in male patients with severe growth hormone deficiency.

  2009cites this paper
• Insulin-Like Growth Factors, Cardiovascular Risk Factors, and Cardiovascular Disease

  2009cites this paper
• Studies on novel and traditional risk factors of atherosclerosis

  2009cites this paper
• Smoking and atherosclerotic cardiovascular disease: part II: role of cigarette smoking in cardiovascular disease development.

  2009cites this paper
• The effect of hormone therapy on surrogate measures of cardiovascular disease: lessons learned.

  2008cites this paper
• Glucose–insulin homeostasis, lipid profiles and GH-IGF-IGFBP axis in clozapine-treated schizophrenic obesity versus non-psychiatric obesity

  2008cites this paper
• P-77 Relationships between serum insulin-like growth factor-I levels, blood pressure and glucose tolerance: an observational, exploratory study in 404 subjects

  2008cites this paper
• Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study

  2008cites this paper
• GH and IGF‐I deficiency are associated with reduced loss of fat mass after laparoscopic‐adjustable silicone gastric banding

  2008cites this paper
• Plaque imaging: clinical implications and use of invasive methods

  2008cites this paper
• The role of IGF‐I and its binding proteins in the development of type 2 diabetes and cardiovascular disease

  2008cites this paper
• Role of IGF-1 in glucose regulation and cardiovascular disease

  2008cites this paper
• Relationships between serum IGF1 levels, blood pressure, and glucose tolerance: an observational, exploratory study in 404 subjects.

  2008cites this paper
• The GH–IGF‐I axis and the cardiovascular system: clinical implications

  2008cites this paper
• Alterations in body composition in acromegaly

  2008cites this paper
• Social differences in insulin-like growth factor-1: findings from a British birth cohort.

  2008cites this paper
• A retrospective analysis on biochemical parameters, cardiovascular risk and cardiomyopathy in elderly acromegalic patients

  2007cites this paper
• Serum insulin-like growth factor-I (IGF-I) IGF binding protein-3 (IGFBP-3) and leptin levels are related to abdominal aortic intima-media thickness in macrosomic newborns.

  2007cites this paper
• Sztywność tętnicza u chorych na niedoczynność przysadki z długoletnim niedoborem hormonu wzrostu Arterial stiffness in hypopituitary patients with life-long growth hormone deficiency

  2007cites this paper
• [Arterial stiffness in hypopituitary patients with life-long growth hormone deficiency].

  2007cites this paper
• Induction of cellular senescence by insulin-like growth factor binding protein-5 through a p53-dependent mechanism.

  2007cites this paper
• Role of growth hormone, insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 in development of non-alcoholic fatty liver disease

  2007cites this paper
• Pleiotropic QTL on Chromosome 12q23–q24 Influences Triglyceride and High-Density Lipoprotein Cholesterol Levels: The HERITAGE Family Study

  2006cites this paper
• The natural history of partial growth hormone deficiency in adults: a prospective study on the cardiovascular risk and atherosclerosis.

  2006cites this paper
• Beginning to end: cardiovascular implications of growth hormone (GH) deficiency and GH therapy.

  2006cites this paper
• Does a gender-related effect of growth hormone (GH) replacement exist on cardiovascular risk factors, cardiac morphology, and performance and atherosclerosis? Results of a two-year open, prospective study in young adult men and women with severe GH deficiency.

  2005cites this paper